文献速递冠心病心力衰竭与心肌病

心肌梗死后射血分数降低且无房颤患者的卒中风险评分

Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究基于4项临床试验(CAPRICORN、OPTIMAAL、VALIANT、EPHESUS)的22,904例无房颤或口服抗凝的MI后HF和/或收缩功能不全患者,识别卒中的非房颤危险因素并建立风险评分,EPHESUS用于外部验证。中位随访1.9年期间660例(2.9%)发生卒中,最终模型纳入年龄、Killip 3/4级、eGFR≤45、高血压史和既往卒中,C指数0.67,3年事件率随评分六分位递增(1.8%至10.9%)。

要点

  • MI后HF和/或收缩功能不全且无房颤患者中,年龄、Killip 3/4级、eGFR≤45、高血压史和既往卒中是卒中独立危险因素。
  • 风险评分校准良好,区分度中等(C指数0.67),3年卒中率从1.8%至10.9%随评分升高而递增。
  • 该评分有助于识别无房颤但卒中高风险的心梗后心衰患者。

核心结论

  • 在无房颤或口服抗凝的MI后HF和/或收缩功能不全患者中,基于常见临床因素建立的卒中风险评分校准良好且区分度中等,有助于识别高风险患者。

研究设计与样本

  • 汇总分析4项试验(CAPRICORN、OPTIMAAL、VALIANT、EPHESUS)数据,EPHESUS用于外部验证。
  • 共纳入22,904例无房颤或口服抗凝的患者,主要终点为卒中,死亡作为竞争风险。

主要发现

  • 中位随访1.9年(IQR 1.3-2.7年)期间,660例(2.9%)发生卒中。
  • 卒中患者年龄更大、女性更多、吸烟和高血压比例更高、Killip分级更高、eGFR更低,且MI、HF、糖尿病和卒中史比例更高。
  • 最终模型保留年龄、Killip 3或4级、eGFR≤45 ml/min/1.73 m2、高血压史和既往卒中,C指数=0.67。
  • 3年观察事件率随风险评分六分位递增:1.8%、2.9%、4.1%、5.6%、8.3%、10.9%,与预期事件率一致。

关键数值与推荐

  • 风险评分纳入因素:年龄、Killip 3或4级、eGFR≤45 ml/min/1.73 m2、高血压史、既往卒中。
  • 模型区分度C指数=0.67,校准良好。
  • 3年卒中事件率按评分六分位分别为1.8%、2.9%、4.1%、5.6%、8.3%、10.9%。

临床怎么用

  • 对于MI后HF和/或收缩功能不全且无房颤的患者,可使用该评分评估卒中风险,辅助识别高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stroke can occur after myocardial infarction (MI) in the absence of atrial fibrillation (AF). OBJECTIVES: This study sought to identify risk factors (excluding AF) for the occurrence of stroke and to develop a calibrated and validated stroke risk score in patients with MI and heart failure (HF) and/or systolic dysfunction. METHODS: The datasets included in this pooling initiative were derived from 4 trials: CAPRICORN (Effect of Carvedilol on Outcome After Myocardial Infarction in Patients With Left Ventricular Dysfunction), OPTIMAAL (Optimal Trial in Myocardial Infarction With Angiotensin II Antagonist Losartan), VALIANT (Valsartan in Acute Myocardial Infarction Trial), and EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study); EPHESUS was used for external validation. A total of 22,904 patients without AF or oral anticoagulation were included in this analysis. The primary outcome was stroke, and death was treated as a "competing risk." RESULTS: During a median follow-up of 1.9 years (interquartile range: 1.3 to 2.7 years), 660 (2.9%) patients had a stroke. These patients were older, more often female, smokers, and hypertensive; they had a higher Killip class; a lower estimated glomerular filtration rate; and a higher proportion of MI, HF, diabetes, and stroke histories. The final stroke risk model retained older age, Killip class 3 or 4, estimated glomerular filtration rate ≤45 ml/min/1.73 m2, hypertension history, and previous stroke. The models were well calibrated and showed moderate to good discrimination (C-index = 0.67). The observed 3-year event rates increased steeply for each sextile of the stroke risk score (1.8%, 2.9%, 4.1%, 5.6%, 8.3%, and 10.9%, respectively) and were in agreement with the expected event rates. CONCLUSIONS: Readily accessible risk factors associated with the occurrence of stroke were identified and incorporated in an easy-to-use risk score. This score may help in the identification of patients with MI and HF and a high risk for stroke despite their not presenting with AF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ferreira JP, Girerd N, Gregson J, et al. Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. J Am Coll Cardiol. 2018. PMID: 29447733. doi:10.1016/j.jacc.2017.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。